These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8647574)
21. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323 [TBL] [Abstract][Full Text] [Related]
22. A prospective study of pravastatin in the elderly at risk: new hope for older persons. Shepherd J Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):17-24. PubMed ID: 15133425 [TBL] [Abstract][Full Text] [Related]
23. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ; Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811 [TBL] [Abstract][Full Text] [Related]
24. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials. Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
26. Reduction in coronary events during treatment with pravastatin. PLAC I and PLAC II Investigators. Pravastatin Limitation of Atherosclerosis in the Coronary Arteries. Furberg CD; Pitt B; Byington RP; Park JS; McGovern ME Am J Cardiol; 1995 Sep; 76(9):60C-63C. PubMed ID: 7572689 [TBL] [Abstract][Full Text] [Related]
27. Pravastatin therapy and the risk of stroke. White HD; Simes RJ; Anderson NE; Hankey GJ; Watson JD; Hunt D; Colquhoun DM; Glasziou P; MacMahon S; Kirby AC; West MJ; Tonkin AM N Engl J Med; 2000 Aug; 343(5):317-26. PubMed ID: 10922421 [TBL] [Abstract][Full Text] [Related]
28. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694 [TBL] [Abstract][Full Text] [Related]
29. Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Söderberg S; Colquhoun D; Keech A; Yallop J; Barnes EH; Pollicino C; Simes J; Tonkin AM; Nestel P; Int J Obes (Lond); 2009 Jan; 33(1):123-30. PubMed ID: 19050671 [TBL] [Abstract][Full Text] [Related]
30. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262 [TBL] [Abstract][Full Text] [Related]
31. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Lewis SJ; Moye LA; Sacks FM; Johnstone DE; Timmis G; Mitchell J; Limacher M; Kell S; Glasser SP; Grant J; Davis BR; Pfeffer MA; Braunwald E Ann Intern Med; 1998 Nov; 129(9):681-9. PubMed ID: 9841599 [TBL] [Abstract][Full Text] [Related]
32. Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events. Arntz HR Atherosclerosis; 1999 Sep; 147 Suppl 1():S17-21. PubMed ID: 10575058 [TBL] [Abstract][Full Text] [Related]
33. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. Marschner IC; Colquhoun D; Simes RJ; Glasziou P; Harris P; Singh BB; Friedlander D; White H; Thompson P; Tonkin A; J Am Coll Cardiol; 2001 Jul; 38(1):56-63. PubMed ID: 11451296 [TBL] [Abstract][Full Text] [Related]
35. Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study. Hague WE; Simes J; Kirby A; Keech AC; White HD; Hunt D; Nestel PJ; Colquhoun DM; Pater H; Stewart RA; Sullivan DR; Thompson PL; West M; Glasziou PP; Tonkin AM; Circulation; 2016 May; 133(19):1851-60. PubMed ID: 27016105 [TBL] [Abstract][Full Text] [Related]
36. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. Sacks FM; Pfeffer MA; Moye LA; Rouleau JL; Rutherford JD; Cole TG; Brown L; Warnica JW; Arnold JM; Wun CC; Davis BR; Braunwald E N Engl J Med; 1996 Oct; 335(14):1001-9. PubMed ID: 8801446 [TBL] [Abstract][Full Text] [Related]
37. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. de Groot E; Jukema JW; van Boven AJ; Reiber JH; Zwinderman AH; Lie KI; Ackerstaff RA; Bruschke AV Am J Cardiol; 1995 Sep; 76(9):40C-46C. PubMed ID: 7572685 [TBL] [Abstract][Full Text] [Related]
38. Statins and secondary prevention of coronary heart disease. Ahmed M; Griffiths P Br J Community Nurs; 2004 Apr; 9(4):160-5. PubMed ID: 15150487 [TBL] [Abstract][Full Text] [Related]
39. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023 [TBL] [Abstract][Full Text] [Related]
40. Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Wright RS; Murphy JG; Bybee KA; Kopecky SL; LaBlanche JM Mayo Clin Proc; 2002 Oct; 77(10):1085-92. PubMed ID: 12374252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]